ALLISON MARTIN: Open Payments
NPI 1154567212 · KENEDY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$624 in 22 payments from 10 companies in 2025. Trend: 2023 $660 · 2024 $911 · 2025 $624
Food & beverage: $624
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 3 | $182 |
| Janssen Biotech, Inc. | 5 | $99 |
| Lilly USA, LLC | 1 | $86 |
| PFIZER INC. | 4 | $79 |
| Regeneron Healthcare Solutions, Inc. | 2 | $55 |
| ABBVIE INC. | 2 | $48 |
| Organon LLC | 2 | $32 |
| GENZYME CORPORATION | 1 | $18 |
| Novartis Pharmaceuticals Corporation | 1 | $14 |
| Echosens North America, Inc. | 1 | $10 |
Products named: Bimzelx, TREMFYA, CIBINQO, DUPIXENT, RINVOQ, SKYRIZI, VTAMA, COSENTYX.
Industry payments across TX — which companies pay providers there.
